Correlation Between Aclaris Therapeutics and Charles River
Can any of the company-specific risk be diversified away by investing in both Aclaris Therapeutics and Charles River at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aclaris Therapeutics and Charles River into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aclaris Therapeutics and Charles River Laboratories, you can compare the effects of market volatilities on Aclaris Therapeutics and Charles River and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aclaris Therapeutics with a short position of Charles River. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aclaris Therapeutics and Charles River.
Diversification Opportunities for Aclaris Therapeutics and Charles River
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Aclaris and Charles is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Aclaris Therapeutics and Charles River Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Charles River Labora and Aclaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aclaris Therapeutics are associated (or correlated) with Charles River. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Charles River Labora has no effect on the direction of Aclaris Therapeutics i.e., Aclaris Therapeutics and Charles River go up and down completely randomly.
Pair Corralation between Aclaris Therapeutics and Charles River
Given the investment horizon of 90 days Aclaris Therapeutics is expected to generate 3.01 times more return on investment than Charles River. However, Aclaris Therapeutics is 3.01 times more volatile than Charles River Laboratories. It trades about 0.18 of its potential returns per unit of risk. Charles River Laboratories is currently generating about -0.02 per unit of risk. If you would invest 105.00 in Aclaris Therapeutics on August 24, 2024 and sell it today you would earn a total of 327.00 from holding Aclaris Therapeutics or generate 311.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 99.21% |
| Values | Daily Returns |
Aclaris Therapeutics vs. Charles River Laboratories
Performance |
| Timeline |
| Aclaris Therapeutics |
| Charles River Labora |
Aclaris Therapeutics and Charles River Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aclaris Therapeutics and Charles River
The main advantage of trading using opposite Aclaris Therapeutics and Charles River positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aclaris Therapeutics position performs unexpectedly, Charles River can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Charles River will offset losses from the drop in Charles River's long position.| Aclaris Therapeutics vs. Neogen | Aclaris Therapeutics vs. Qiagen NV | Aclaris Therapeutics vs. Sotera Health Co | Aclaris Therapeutics vs. RadNet Inc |
| Charles River vs. ICON PLC | Charles River vs. Mettler Toledo International | Charles River vs. Laboratory of | Charles River vs. Waters |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |